Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School

Last Updated: January 25, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019795

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

NDA 019795 describes CONDYLOX, which is a drug marketed by Allergan and is included in two NDAs. It is available from two suppliers. Additional details are available on the CONDYLOX profile page.

The generic ingredient in CONDYLOX is podofilox. There are two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the podofilox profile page.
Summary for 019795
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 019795
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CONDYLOX podofilox SOLUTION;TOPICAL 019795 NDA AUTHORIZED GENERIC Actavis Pharma, Inc. 0591-3204 0591-3204-13 3.5 mL in 1 BOTTLE, GLASS (0591-3204-13)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;TOPICALStrength0.5%
Approval Date:Dec 13, 1990TE:ATRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.